$ORGS
Orgenesis Inc. Stock $orgs

$orgs Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-K Financial Statement

#000106299320001299 Filed on March 09, 2020

Income Statement

Concept	2020 Q1	2019 Q4	2019
Revenue	$1.880M	$1.120M	$33.26M
YoY Change	347.62%	-39.52%	78.27%
Cost Of Revenue			$18.23M
YoY Change			68.44%
Gross Profit			$15.02M
YoY Change			91.85%
Gross Profit Margin			45.18%
Selling, General & Admin	$3.240M	$2.730M	$10.19M
YoY Change	22.26%	-44.96%	442.02%
% of Gross Profit			67.82%
Research & Development	$5.080M	$2.950M	$12.46M
YoY Change	-12.56%	106.15%	92.73%
% of Gross Profit			82.92%
Depreciation & Amortization	$490.0K	$970.0K	$1.745M
YoY Change	-47.87%	1027.91%	59.22%
% of Gross Profit			11.61%
Operating Expenses	$8.610M	$5.940M	$12.46M
YoY Change	2.62%	315.09%	92.73%
Operating Profit			-$24.60M
YoY Change			76.77%
Interest Expense	-$480.0K	-$540.0K	-$960.0K
YoY Change	500.0%	-164.29%	2300.0%
% of Operating Profit
Other Income/Expense, Net	$150.0K	$290.0K	-$874.0K
YoY Change	-850.0%	-1174.07%	-71.96%
Pretax Income	-$7.060M	-$5.070M	-$25.48M
YoY Change	-15.75%	69.57%	43.4%
Income Tax	-$50.00K	-$120.0K	$563.0K
% Of Pretax Income
Net Earnings	-$75.02M	-$6.060M	-$24.12M
YoY Change	-987.86%	120.85%	31.87%
Net Earnings / Revenue	-3990.64%	-541.07%	-72.53%
Basic Earnings Per Share			-$1.77
Diluted Earnings Per Share	$3.936M	-$377.3K	-$1.77
COMMON SHARES
Basic Shares Outstanding	18.36M shares	16.16M shares	15.91M shares
Diluted Shares Outstanding			15.91M shares

Balance Sheet

Concept	2020 Q1	2019 Q4	2019
SHORT-TERM ASSETS
Cash & Short-Term Investments	$107.1M	$100.0K	$110.0K
YoY Change	643.75%	-99.38%	-99.25%
Cash & Equivalents	$107.7M	$12.04M	$110.0K
Short-Term Investments
Other Short-Term Assets	$2.700M	$76.10M	$76.07M
YoY Change	92.86%	5753.85%	4904.61%
Inventory	$100.0K	$2.043M	$140.0K
Prepaid Expenses		$1.227M
Receivables	$2.900M	$8.485M	$1.830M
Other Receivables	$200.0K	$200.0K	$210.0K
Total Short-Term Assets	$112.9M	$25.98M	$78.35M
YoY Change	372.38%	-7.41%	179.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.100M	$24.45M	$3.030M
YoY Change	-88.56%	96.29%	-75.68%
Goodwill		$14.94M
YoY Change		-1.48%
Intangibles		$14.21M
YoY Change		-14.64%
Long-Term Investments
YoY Change
Other Assets	$400.0K	$82.00K	$330.0K
YoY Change	-50.0%	-72.39%	-25.0%
Total Long-Term Assets	$14.30M	$66.52M	$14.15M
YoY Change	-76.52%	45.17%	-69.12%
TOTAL ASSETS
Total Short-Term Assets	$112.9M	$25.98M	$78.35M
Total Long-Term Assets	$14.30M	$66.52M	$14.15M
Total Assets	$127.2M	$92.50M	$92.50M
YoY Change	50.0%	25.2%	25.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.400M	$11.31M	$5.550M
YoY Change	-74.55%	146.67%	21.18%
Accrued Expenses	$3.900M	$1.987M	$3.640M
YoY Change	-33.9%	32.56%	-20.0%
Deferred Revenue	$396.0K	$8.626M
YoY Change		62.23%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$400.0K	$800.0K	$810.0K
YoY Change	-66.67%	-20.0%	-35.2%
Total Short-Term Liabilities	$25.90M	$31.58M	$42.43M
YoY Change	18.81%	84.02%	147.26%
LONG-TERM LIABILITIES
Long-Term Debt	$10.90M	$12.10M	$12.14M
YoY Change	220.59%	348.15%	245.87%
Other Long-Term Liabilities	$700.0K	$331.0K	$830.0K
YoY Change	-94.35%	11.45%	43.1%
Total Long-Term Liabilities	$11.60M	$23.88M	$12.97M
YoY Change	-26.58%	316.01%	217.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.90M	$31.58M	$42.43M
Total Long-Term Liabilities	$11.60M	$23.88M	$12.97M
Total Liabilities	$37.70M	$55.46M	$87.02M
YoY Change	-41.09%	142.17%	82.16%
SHAREHOLDERS EQUITY
Retained Earnings		-$89.43M
YoY Change		37.24%
Common Stock		$2.000K
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$89.50M	$5.477M	$5.480M
YoY Change
Total Liabilities & Shareholders Equity	$127.2M	$92.50M	$92.50M
YoY Change	50.0%	25.2%	25.2%

Cashflow Statement

Concept	2020 Q1	2019 Q4	2019
OPERATING ACTIVITIES
Net Income	-$75.02M	-$6.060M	-$24.12M
YoY Change	-987.86%	120.85%	31.87%
Depreciation, Depletion And Amortization	$490.0K	$970.0K	$1.745M
YoY Change	-47.87%	1027.91%	59.22%
Cash From Operating Activities	-$13.69M	-$2.710M	-$13.22M
YoY Change	203.55%	151.62%	-15.7%
INVESTING ACTIVITIES
Capital Expenditures	$699.0K	-$6.010M	$12.13M
YoY Change	-32.66%	-1223.36%	118.3%
Acquisitions
YoY Change
Other Investing Activities	$103.7M	-$500.0K	-$1.650M
YoY Change	-7900.0%	-45.65%	2744.83%
Cash From Investing Activities	$103.0M	-$6.510M	-$13.78M
YoY Change	-4460.77%	999.66%	119.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$6.357M	10.42M	$24.10M
YoY Change	-3.71%	5189.34%	-31.27%
NET CHANGE
Cash From Operating Activities	-$13.69M	-2.710M	-$13.22M
Cash From Investing Activities	$103.0M	-6.510M	-$13.78M
Cash From Financing Activities	$6.357M	10.42M	$24.10M
Net Change In Cash	$95.71M	1.200M	-$2.900M
YoY Change	-35287.13%	-181.52%	-122.12%
FREE CASH FLOW
Cash From Operating Activities	-$13.69M	-$2.710M	-$13.22M
Capital Expenditures	$699.0K	-$6.010M	$12.13M
Free Cash Flow	-$14.39M	$3.300M	-$25.35M
YoY Change	159.36%	-304.71%	19.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001460602
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019	dei	Entity Small Business EntitySmallBusiness	true
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Entity Registrant Name EntityRegistrantName	Orgenesis Inc.
CY2019	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2019	dei	Trading Symbol TradingSymbol	ORGS
CY2019	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18361050	shares
CY2019Q2	dei	Entity Public Float EntityPublicFloat	56803434	USD
CY2019Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	11388000	USD
CY2018Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	14612000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	653000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	387000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8485000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3226000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4151000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1227000	USD
CY2018Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1132000	USD
CY2018Q4	orgs	Gpp Receivable GPPReceivable	6600000	USD
CY2019Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	2183000	USD
CY2018Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	441000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	2043000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	1660000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	25979000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	28058000	USD
CY2019Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	625000	USD
CY2018Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	143000	USD
CY2019Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	2623000	USD
CY2018Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	1012000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	14941000	USD
CY2018Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	1007000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24454000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12458000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14206000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16642000	USD
CY2018Q4	orgs	Redeemable Non Controlling Interest RedeemableNonControllingInterest	24224000	USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9585000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	15266000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	10684000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	15165000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	82000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	297000	USD
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	66516000	USD
CY2018Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	45818000	USD
CY2019Q4	us-gaap	Assets Assets	92495000	USD
CY2018Q4	us-gaap	Assets Assets	73876000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11305000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4583000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1987000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1499000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3719000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3052000	USD
CY2019Q4	orgs	Advance Payment On Account Of Grant AdvancePaymentOnAccountOfGrant	2750000	USD
CY2018Q4	orgs	Advance Payment On Account Of Grant AdvancePaymentOnAccountOfGrant	1603000	USD
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	763000	USD
CY2018Q4	us-gaap	Notes Payable Current NotesPayableCurrent	641000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8626000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5175000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5317000	USD
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	291000	USD
CY2018Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	226000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1722000	USD
CY2019Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	416000	USD
CY2018Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	382000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	31579000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17161000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7524000	USD
CY2019Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	1230000	USD
CY2018Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	1633000	USD
CY2019Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	12143000	USD
CY2018Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1214000	USD
CY2019Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	41000	USD
CY2018Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	280000	USD
CY2019Q4	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	1926000	USD
CY2018Q4	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	1656000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	688000	USD
CY2018Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	661000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	331000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	297000	USD
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	23883000	USD
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5741000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	55462000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	22902000	USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	orgs	Redeemable Non Controlling Interest RedeemableNonControllingInterest	30955000	USD
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145833334	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145833334	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16140962	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15540333	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16140962	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15540333	shares
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	94691000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90597000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	213000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	669000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89429000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65163000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	5477000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	26105000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	601000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	645000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6078000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26750000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14123000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28649000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	92495000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	73876000	USD
CY2019	us-gaap	Revenues Revenues	33256000	USD
CY2018	us-gaap	Revenues Revenues	18655000	USD
CY2018Q4	us-gaap	Revenues Revenues	1852000	USD
CY2017Q4	us-gaap	Revenues Revenues	802000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	18232000	USD
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	10824000	USD
CY2018Q4	us-gaap	Cost Of Revenue CostOfRevenue	1221000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12458000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6464000	USD
CY2018Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1431000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2061000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1913000	USD
CY2018Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	179000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25337000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16303000	USD
CY2018Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1984000	USD
CY2019	us-gaap	Other Operating Income OtherOperatingIncome	228000	USD
CY2018	us-gaap	Other Operating Income OtherOperatingIncome	2930000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-24604000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-13919000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2963000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1349000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-874000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3117000	USD
CY2018Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-27000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-731000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-25478000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17767000	USD
CY2018Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2990000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	563000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1337000	USD
CY2018Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-83000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-132000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-26041000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-19104000	USD
CY2018Q4	us-gaap	Profit Loss ProfitLoss	-2907000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	-2056000	USD
CY2019	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-1920000	USD
CY2018	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-813000	USD
CY2018Q4	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-163000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-24121000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-18291000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-2744000	USD
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.77
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.43
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.77
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.43
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15907995	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13374103	shares
CY2018Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15423040	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10367472	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15907995	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13374103	shares
CY2018Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15423040	shares
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10367472	shares
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-456000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1000000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	244000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-26497000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-20104000	USD
CY2018Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2663000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1920000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-813000	USD
CY2018Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-163000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24577000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19291000	USD
CY2018Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2500000	USD
CY2018	orgs	Stock Based Compensation Expenses Related To Options Granted To Employees And Directors StockBasedCompensationExpensesRelatedToOptionsGrantedToEmployeesAndDirectors	2426000	USD
CY2018Q4	orgs	Stock Based Compensation Expenses Related To Options Granted To Employees And Directors StockBasedCompensationExpensesRelatedToOptionsGrantedToEmployeesAndDirectors	629000	USD
CY2019	orgs	Stock Based Compensation Expenses Related To Options Granted To Employees And Directors StockBasedCompensationExpensesRelatedToOptionsGrantedToEmployeesAndDirectors	2164000	USD
CY2018	orgs	Stockbased Compensation Related To Options Granted To Service Providers Including Receipts On Account StockbasedCompensationRelatedToOptionsGrantedToServiceProvidersIncludingReceiptsOnAccount	1938000	USD
CY2018	orgs	Adjustment To Redemption Value Of Redeemable Non Controlling Interest AdjustmentToRedemptionValueOfRedeemableNonControllingInterest	884000	USD
CY2018Q4	orgs	Adjustment To Redemption Value Of Redeemable Non Controlling Interest AdjustmentToRedemptionValueOfRedeemableNonControllingInterest	180000	USD
CY2019	orgs	Adjustment To Redemption Value Of Redeemable Non Controlling Interest AdjustmentToRedemptionValueOfRedeemableNonControllingInterest	4095000	USD
CY2018Q4	orgs	Stockbased Compensation Related To Options Granted To Service Providers Including Receipts On Account StockbasedCompensationRelatedToOptionsGrantedToServiceProvidersIncludingReceiptsOnAccount	105000	USD
CY2019	orgs	Stockbased Compensation Related To Options Granted To Service Providers Including Receipts On Account StockbasedCompensationRelatedToOptionsGrantedToServiceProvidersIncludingReceiptsOnAccount	893000	USD
CY2018	orgs	Stock Warrants Issued During Period Value Conversion Of Convertible Loans And Shares In Escrow Account StockWarrantsIssuedDuringPeriodValueConversionOfConvertibleLoansAndSharesInEscrowAccount	7511000	USD
CY2018	orgs	Issuance Of Shares And Receipts On Account Of Shares To Be Allotted Related To Acquisition Of Atvio And Curecell IssuanceOfSharesAndReceiptsOnAccountOfSharesToBeAllottedRelatedToAcquisitionOfAtvioAndCurecell	2751000	USD
CY2018	orgs	Issuance Of Warrants And Beneficial Conversion Feature Of Convertible Loans IssuanceOfWarrantsAndBeneficialConversionFeatureOfConvertibleLoans	438000	USD
CY2019	orgs	Issuance Of Warrants And Beneficial Conversion Feature Of Convertible Loans IssuanceOfWarrantsAndBeneficialConversionFeatureOfConvertibleLoans	370000	USD
CY2018	orgs	Issuance Of Shares And Receipts On Account Of Shares And Warrants To Be Allotted And Cancelation Of Contingent Shares IssuanceOfSharesAndReceiptsOnAccountOfSharesAndWarrantsToBeAllottedAndCancelationOfContingentShares	18791000	USD
CY2018Q4	orgs	Issuance Of Shares And Receipts On Account Of Shares And Warrants To Be Allotted And Cancelation Of Contingent Shares IssuanceOfSharesAndReceiptsOnAccountOfSharesAndWarrantsToBeAllottedAndCancelationOfContingentShares	1000	USD
CY2018	orgs	Issuance Of Shares Due To Exercise Of Warrants IssuanceOfSharesDueToExerciseOfWarrants	846000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	157000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	134000	USD
CY2018Q4	us-gaap	Interest Paid Net InterestPaidNet	15000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	156000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19291000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2509000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-24679000	USD
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	63000	USD
CY2019	orgs	Stockbased Compensation Value Strategic Collaborations StockbasedCompensationValueStrategicCollaborations	2641000	USD
CY2019	orgs	Transaction With Non Controlling Interest TransactionWithNonControllingInterest	2034000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	3057000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	4364000	USD
CY2018Q4	us-gaap	Share Based Compensation ShareBasedCompensation	734000	USD
CY2019	orgs	Stock Based Compensation Expense To First Choice StockBasedCompensationExpenseToFirstChoice	2641000	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	29000	USD
CY2018	us-gaap	Gain Loss On Investments GainLossOnInvestments	-731000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3806000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2624000	USD
CY2018Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	265000	USD
CY2018	orgs	Net Gain On Remeasurement Of Previously Equity Interest In Atvio And Curecell To Acquisition Date Fair Value NetGainOnRemeasurementOfPreviouslyEquityInterestInAtvioAndCurecellToAcquisitionDateFairValue	4509000	USD
CY2018	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-26000	USD
CY2019	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-339000	USD
CY2019	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	387000	USD
CY2018	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	2564000	USD
CY2018Q4	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	12000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5308000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2901000	USD
CY2018Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-951000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	414000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	931000	USD
CY2018Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-89000	USD
CY2019	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	46000	USD
CY2018	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	19000	USD
CY2018Q4	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	3000	USD
CY2019	orgs	Increase Decrease In Exchange Differences On Inter Company Balances IncreaseDecreaseInExchangeDifferencesOnInterCompanyBalances	-214000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	112000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-380000	USD
CY2018Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	213000	USD
CY2018	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-532000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4626000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-796000	USD
CY2018Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	743000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	271000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	428000	USD
CY2018Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-421000	USD
CY2019	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	474000	USD
CY2018	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	-105000	USD
CY2018Q4	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	45000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3536000	USD
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1309000	USD
CY2018Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-181000	USD
CY2019	orgs	Increase Decrease Increase Decrease In Advance Payment On Account Of Grant IncreaseDecreaseIncreaseDecreaseInAdvancePaymentOnAccountOfGrant	-247000	USD
CY2018	orgs	Increase Decrease Increase Decrease In Advance Payment On Account Of Grant IncreaseDecreaseIncreaseDecreaseInAdvancePaymentOnAccountOfGrant	-193000	USD
CY2018	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1912000	USD
CY2018Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	250000	USD
CY2016Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1000000	ILS
CY2016Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	280000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-173000	USD
CY2018Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14999000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3519000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16456000	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	270000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24098000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35060000	USD
CY2018Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	197000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2900000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	13110000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1472000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-58000	USD
CY2018Q4	orgs	Increase Decrease Increase Decrease In Advance Payment On Account Of Grant IncreaseDecreaseIncreaseDecreaseInAdvancePaymentOnAccountOfGrant	-133000	USD
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	304000	USD
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	982000	USD
CY2018Q4	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-58000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13220000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15682000	USD
CY2018Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1077000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	79000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12129000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5556000	USD
CY2018Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	535000	USD
CY2019	us-gaap	Payments For Deposits PaymentsForDeposits	228000	USD
CY2018	us-gaap	Payments For Deposits PaymentsForDeposits	15000	USD
CY2018Q4	us-gaap	Payments For Deposits PaymentsForDeposits	57000	USD
CY2019	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	-1500000	USD
CY2018	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	-1000000	USD
CY2018	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-58000	USD
CY2018	orgs	Acquisition Of Atvio Net Of Cash Acquired AcquisitionOfAtvioNetOfCashAcquired	245000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13778000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6268000	USD
CY2018Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-592000	USD
CY2019	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	13200000	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17392000	USD
CY2018	orgs	Proceeds From Repayments Of Redeemable Non Controlling Interest ProceedsFromRepaymentsOfRedeemableNonControllingInterest	14058000	USD
CY2018	orgs	Proceeds From Receipts On Account Of Shares To Be Allotted ProceedsFromReceiptsOnAccountOfSharesToBeAllotted	2252000	USD
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt	772000	USD
CY2018	us-gaap	Repayments Of Debt RepaymentsOfDebt	377000	USD
CY2018Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	53000	USD
CY2018	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	177000	USD
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	11400000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12041000	USD
CY2019	us-gaap	Depreciation Depreciation	1745000	USD
CY2018	us-gaap	Depreciation Depreciation	1096000	USD
CY2018	orgs	Conversion Of Loans To Shares Of Common Stock And Warrants ConversionOfLoansToSharesOfCommonStockAndWarrants	7511000	USD
CY2018	orgs	Classification Of Loan Receivable Into Services To Be Received From Curecell ClassificationOfLoanReceivableIntoServicesToBeReceivedFromCurecell	836000	USD
CY2019	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	546000	USD
CY2018	orgs	Receivable From Gpp ReceivableFromGPP	6600000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8229000	USD
CY2019	orgs	Purchase Of Property Plant And Equipment Included In Accounts Payable PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayable	1584000	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	355000	USD
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	955000	USD
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:0px;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><i>a.</i><span style="width:28.5pt;display:inline-block"> </span><i>Use of Estimates in the Preparation of Financial Statements</i></span></span><br/> </p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:36pt;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the financial statement date and the reported expenses during the reporting periods. Actual results could differ from those estimates.</span></span><br/> </p></div>
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:-36pt;font-style:normal;font-weight:400;margin-left:48px;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><i>q.</i><span style="width:28.5pt;text-indent:0pt;display:inline-block"> </span><i>Concentration of Credit Risk</i></span></span><br/> </p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:36pt;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of principally cash and cash equivalents, <span>bank deposits</span> and certain receivables. The Company held these instruments with highly rated financial institutions and the Company has not experienced any significant credit losses in these accounts and does not believe the Company is exposed to any significant credit risk on these instruments apart of accounts receivable. The Company performs ongoing credit evaluations of its customers for the purpose of determining the appropriate allowance for doubtful accounts. An appropriate allowance for doubtful accounts is included in the accounts and netted against accounts receivable. In the year ended December 31, 2019 <span>the Company has not experienced any material credit losses in these accounts and does not believe it is exposed to significant credit risk on these instruments.</span></span></span><br/> </p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);text-align:justify;text-indent:36pt;font-style:normal;font-weight:400;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Bad debt allowance is created when objective evidence exists of inability to collect all sums owed it under the original terms of the debit balances. Material customer difficulties, the probability of their going bankrupt or undergoing economic reorganization and insolvency or material delays in payments are all considered indicative of reduced debtor balance value.</span></span></p></div>
CY2018	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	8056000	USD
CY2018	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1378737	shares
CY2018	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1240972	shares
CY2019	orgs	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	471980	shares
CY2018	orgs	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	4488854	shares
CY2018Q4	orgs	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	2858	shares
CY2018Q1	orgs	Debt Conversion Converted Instrument And Accrued Interest Amount DebtConversionConvertedInstrumentAndAccruedInterestAmount	383000	USD
CY2018Q2	orgs	Repayments Of Convertible Debt Shares Issued RepaymentsOfConvertibleDebtSharesIssued	107985	shares
CY2019	orgs	Segment Performance SegmentPerformance	-18906000	USD
CY2018	orgs	Segment Performance SegmentPerformance	-12743000	USD
CY2018Q4	orgs	Segment Performance SegmentPerformance	-2229000	USD
CY2019	orgs	Sharebased Compensation SharebasedCompensation	-3057000	USD
CY2018	orgs	Sharebased Compensation SharebasedCompensation	-4364000	USD
CY2018Q4	orgs	Sharebased Compensation SharebasedCompensation	-734000	USD
CY2019	orgs	Stock Based Compensation To Strategic Collaborations StockBasedCompensationToStrategicCollaborations	-2641000	USD
CY2019	us-gaap	Investment Income Net InvestmentIncomeNet	-874000	USD
CY2018	us-gaap	Investment Income Net InvestmentIncomeNet	-2938000	USD
CY2018Q4	us-gaap	Investment Income Net InvestmentIncomeNet	-27000	USD
CY2018	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	1500000	USD
CY2019Q4	orgs	Property Plants And Equipment Net And Right Of Use Assets PropertyPlantsAndEquipmentNetAndRightOfUseAssets	34039000	USD
CY2018Q4	orgs	Property Plants And Equipment Net And Right Of Use Assets PropertyPlantsAndEquipmentNetAndRightOfUseAssets	12458000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	31068000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17270000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6614000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4812000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1993000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7741000	USD
CY2019Q4	us-gaap	Convertible Debt ConvertibleDebt	12900000	USD
CY2016Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.02	pure
CY2018Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.52
CY2018	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	494000	USD
CY2019Q4	us-gaap	Loans Payable LoansPayable	1602000	USD
CY2018Q4	us-gaap	Loans Payable LoansPayable	2004000	USD
CY2019Q4	us-gaap	Loans Payable Current LoansPayableCurrent	372000	USD
CY2018Q4	us-gaap	Loans Payable Current LoansPayableCurrent	371000	USD
CY2019	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification	2909000	USD
CY2018Q4	us-gaap	Depreciation Depreciation	86000	USD
CY2018	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4918000	USD
CY2018	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	437000	USD
CY2018Q4	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-101000	USD
CY2019	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	325000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	22657000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23520000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8451000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6878000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14206000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16642000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	8310000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	13717000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1029000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4471000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.056	pure
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y
CY2019Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2019Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	1994000	USD
CY2019	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	214000	USD
CY2019	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	20000	USD
CY2019	orgs	Finance Lease Cost FinanceLeaseCost	234000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	2320000	USD
CY2019	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	267000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	355000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1532000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	314000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1145000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	252000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1032000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	233000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	925000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	174000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	773000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	56000	USD
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6286351	shares
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2609864	shares
CY2019Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	50000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9246000	USD
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	979000	USD
CY2018Q4	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	783000	USD
CY2018Q4	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	626000	USD
CY2018Q4	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	3504000	USD
CY2018Q4	us-gaap	Other Commitment OtherCommitment	4913000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1321000	USD
CY2018Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	795000	USD
CY2018	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2018	orgs	Reductions To Equity Method Investments Due To Acquisition ReductionsToEquityMethodInvestmentsDueToAcquisition	205000	USD
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6512991	shares
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6010087	shares
CY2018Q4	orgs	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	6.29
CY2017Q4	orgs	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	6.26
CY2018Q4	orgs	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	6.27
CY2019Q4	orgs	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	6.35
CY2019	orgs	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	6.95
CY2018	orgs	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	6.27
CY2018Q4	orgs	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	7.00
CY2019	orgs	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0	shares
CY2018	orgs	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	136646	shares
CY2018Q4	orgs	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0	shares
CY2019	orgs	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	0
CY2018	orgs	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	6.24
CY2018Q4	orgs	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	0
CY2019	orgs	Class Of Warrant Or Right Expirations In Period ClassOfWarrantOrRightExpirationsInPeriod	748244	shares
CY2018	orgs	Class Of Warrant Or Right Expirations In Period ClassOfWarrantOrRightExpirationsInPeriod	382414	shares
CY2018Q4	orgs	Class Of Warrant Or Right Expirations In Period ClassOfWarrantOrRightExpirationsInPeriod	229498	shares
CY2019	orgs	Class Of Warrant Or Right Expirations In Period Weighted Average Exercise Price ClassOfWarrantOrRightExpirationsInPeriodWeightedAverageExercisePrice	6.24
CY2018	orgs	Class Of Warrant Or Right Expirations In Period Weighted Average Exercise Price ClassOfWarrantOrRightExpirationsInPeriodWeightedAverageExercisePrice	6.10
CY2018Q4	orgs	Class Of Warrant Or Right Expirations In Period Weighted Average Exercise Price ClassOfWarrantOrRightExpirationsInPeriodWeightedAverageExercisePrice	6.24
CY2019	orgs	Class Of Warrant Or Right Forfeitures In Period ClassOfWarrantOrRightForfeituresInPeriod	0	shares
CY2018	orgs	Class Of Warrant Or Right Forfeitures In Period ClassOfWarrantOrRightForfeituresInPeriod	66667	shares
CY2018Q4	orgs	Class Of Warrant Or Right Forfeitures In Period ClassOfWarrantOrRightForfeituresInPeriod	0	shares
CY2019	orgs	Class Of Warrant Or Right Forfeitures In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice	0
CY2018	orgs	Class Of Warrant Or Right Forfeitures In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice	6.24
CY2018Q4	orgs	Class Of Warrant Or Right Forfeitures In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice	0
CY2018Q4	orgs	Warrants Subject To Exercise Price Adjustments WarrantsSubjectToExercisePriceAdjustments	542465	shares
CY2018Q4	orgs	Warrants Subject To Exercise Price Adjustments WarrantsSubjectToExercisePriceAdjustments	769411	shares
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28216000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19175000	USD
CY2018Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2924000	USD
CY2019	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-28216000	USD
CY2018	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-19175000	USD
CY2018Q4	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-2924000	USD
CY2019	orgs	Net Income Loss For Period NetIncomeLossForPeriod	-28216000	USD
CY2018	orgs	Net Income Loss For Period NetIncomeLossForPeriod	-19175000	USD
CY2018Q4	orgs	Net Income Loss For Period NetIncomeLossForPeriod	-2924000	USD
CY2019	orgs	Weighted Average Number Of Shares Used In Computation Of Basic Loss Per Share WeightedAverageNumberOfSharesUsedInComputationOfBasicLossPerShare	15907995	shares
CY2018	orgs	Weighted Average Number Of Shares Used In Computation Of Basic Loss Per Share WeightedAverageNumberOfSharesUsedInComputationOfBasicLossPerShare	13374103	shares
CY2018Q4	orgs	Weighted Average Number Of Shares Used In Computation Of Basic Loss Per Share WeightedAverageNumberOfSharesUsedInComputationOfBasicLossPerShare	15423040	shares
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14807000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9765000	USD
CY2019Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	2172000	USD
CY2018Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3065000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	314000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	181000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	36000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	51000	USD
CY2019Q4	orgs	Deferred Tax Liabilities Loans DeferredTaxLiabilitiesLoans	0	USD
CY2018Q4	orgs	Deferred Tax Liabilities Loans DeferredTaxLiabilitiesLoans	117000	USD
CY2019Q4	orgs	Deferred Tax Assets Contract Liabilities DeferredTaxAssetsContractLiabilities	104000	USD
CY2018Q4	orgs	Deferred Tax Assets Contract Liabilities DeferredTaxAssetsContractLiabilities	118000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3452000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4115000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	11000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15638000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10266000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8358000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9235000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1926000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1656000	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5372000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	877000	USD
CY2018Q4	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1031000	USD
CY2019	orgs	Accounts Receivable Additions AccountsReceivableAdditions	26148000	USD
CY2018Q4	orgs	Accounts Receivable Additions AccountsReceivableAdditions	1612000	USD
CY2019	orgs	Accounts Receivable Collections AccountsReceivableCollections	20803000	USD
CY2018Q4	orgs	Accounts Receivable Collections AccountsReceivableCollections	2561000	USD
CY2019	orgs	Accounts Receivable Exchange Rate Differences AccountsReceivableExchangeRateDifferences	86000	USD
CY2018Q4	orgs	Accounts Receivable Exchange Rate Differences AccountsReceivableExchangeRateDifferences	-24000	USD
CY2019	orgs	Revenue Contract With Customer Liability RevenueContractWithCustomerLiability	0	USD
CY2018Q4	orgs	Revenue Contract With Customer Liability RevenueContractWithCustomerLiability	-8000	USD
CY2019	orgs	Contract With Customer Liability Addition ContractWithCustomerLiabilityAddition	9850000	USD
CY2018Q4	orgs	Contract With Customer Liability Addition ContractWithCustomerLiabilityAddition	28000	USD
CY2019	orgs	Contract With Customer Liability Realizations ContractWithCustomerLiabilityRealizations	6307000	USD
CY2018Q4	orgs	Contract With Customer Liability Realizations ContractWithCustomerLiabilityRealizations	251000	USD
CY2019	orgs	Contract With Customer Liability Exchange Rate Dfifferences ContractWithCustomerLiabilityExchangeRateDfifferences	-92000	USD
CY2018Q4	orgs	Contract With Customer Liability Exchange Rate Dfifferences ContractWithCustomerLiabilityExchangeRateDfifferences	89000	USD
CY2019Q4	orgs	Contract With Customer Liability Realizations As Of Date ContractWithCustomerLiabilityRealizationsAsOfDate	4897000	USD
CY2018Q4	us-gaap	Other Income OtherIncome	8000	USD
CY2019	orgs	Total Financial Expenses TotalFinancialExpenses	874000	USD
CY2019	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	13432000	USD
CY2018	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	7386000	USD
CY2018Q4	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1558000	USD
CY2018	orgs	Total Financial Expenses TotalFinancialExpenses	3117000	USD
CY2018Q4	orgs	Total Financial Expenses TotalFinancialExpenses	27000	USD
CY2019	orgs	Increases In Fair Value Of Warrants And Financial Liabilities Measured At Fair Value IncreasesInFairValueOfWarrantsAndFinancialLiabilitiesMeasuredAtFairValue	63000	USD
CY2018	orgs	Increases In Fair Value Of Warrants And Financial Liabilities Measured At Fair Value IncreasesInFairValueOfWarrantsAndFinancialLiabilitiesMeasuredAtFairValue	48000	USD
CY2018Q4	orgs	Increases In Fair Value Of Warrants And Financial Liabilities Measured At Fair Value IncreasesInFairValueOfWarrantsAndFinancialLiabilitiesMeasuredAtFairValue	0	USD
CY2019	orgs	Stock Based Compensation Related To Warrants Granted Due To Issuance Of Credit Facility StockBasedCompensationRelatedToWarrantsGrantedDueToIssuanceOfCreditFacility	0	USD
CY2018	orgs	Stock Based Compensation Related To Warrants Granted Due To Issuance Of Credit Facility StockBasedCompensationRelatedToWarrantsGrantedDueToIssuanceOfCreditFacility	180000	USD
CY2018Q4	orgs	Stock Based Compensation Related To Warrants Granted Due To Issuance Of Credit Facility StockBasedCompensationRelatedToWarrantsGrantedDueToIssuanceOfCreditFacility	0	USD
CY2019	orgs	Interest Expense On Convertible Loans InterestExpenseOnConvertibleLoans	657000	USD
CY2018	orgs	Interest Expense On Convertible Loans InterestExpenseOnConvertibleLoans	2753000	USD
CY2018Q4	orgs	Interest Expense On Convertible Loans InterestExpenseOnConvertibleLoans	40000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-350000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-129000	USD
CY2018Q4	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	5000	USD
CY2019	us-gaap	Other Income OtherIncome	196000	USD
CY2018	us-gaap	Other Income OtherIncome	-7000	USD

Files In Submission

Name	View Source	Status
0001062993-20-001299-index-headers.html	Edgar Link	pending
0001062993-20-001299-index.html	Edgar Link	pending
0001062993-20-001299.txt	Edgar Link	pending
0001062993-20-001299-xbrl.zip	Edgar Link	pending
exhibit21-1.htm	Edgar Link	pending
exhibit23-1.htm	Edgar Link	pending
exhibit23-1xu001.jpg	Edgar Link	pending
exhibit31-1.htm	Edgar Link	pending
exhibit31-2.htm	Edgar Link	pending
exhibit32-1.htm	Edgar Link	pending
exhibit32-2.htm	Edgar Link	pending
exhibit4-1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10k.htm	Edgar Link	pending
form10kx001.jpg	Edgar Link	pending
form10kx002.jpg	Edgar Link	pending
orgs-20191231.xml	Edgar Link	completed
orgs-20191231.xsd	Edgar Link	pending
orgs-20191231_cal.xml	Edgar Link	unprocessable
orgs-20191231_def.xml	Edgar Link	unprocessable
orgs-20191231_lab.xml	Edgar Link	unprocessable
orgs-20191231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGS
Orgenesis Inc. Stock $orgs

2020 Q1 Form 10-K Financial Statement

#000106299320001299 Filed on March 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS Orgenesis Inc. Stock $orgs

2020 Q1 Form 10-K Financial Statement

#000106299320001299 Filed on March 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS
Orgenesis Inc. Stock $orgs